The US Food and Drug Administration (USFDA) has refuted claims that it would be postponing all infant formula import applications under its expedited scheme.
You May Also Like

Global conference on infant nutrition in Wellington
INCOctober 17, 2022

‘Possible opportunity’: ANZ infant nutrition firms gear up for US market entry amid formula shortage
INCJune 27, 2022

Beyond mimicking breastmilk: Why infant nutrition R&D should assess gut-brain axis and benefits into adulthood
INCMay 16, 2022